Two case reports of skin vasculitis following the COVID-19 immunization

The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two...

Descripción completa

Detalles Bibliográficos
Autores principales: Chomičienė, Anželika, Černiauskas, Kęstutis, Linauskienė, Kotryna, Meškauskas, Raimundas, Malinauskienė, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743192/
https://www.ncbi.nlm.nih.gov/pubmed/36561846
http://dx.doi.org/10.1515/med-2022-0608
Descripción
Sumario:The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two case reports of difficult-to-treat skin vasculitis due to COVID-19 vaccination that were successfully treated in a tertiary-level university hospital. When encountering systemic treatment, resistant skin vasculitis plasmapheresis could be a choice of treatment.

Ejemplares similares